​

Funding Round

Series A - Tenpoint Therapeutics

Series A - Tenpoint Therapeutics

Investment Firm

Overview

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Announced Date

Jul 12, 2023

Funding Type

Series A

Highlights

Location

Europe

Social

Investor Lead

F-Prime Capital

F-Prime Capital

F-Prime Capital is a early_stage_venture and late_stage_venture and seed and venture firm.

Sofinnova Partners

Sofinnova Partners

Sofinnova Partners is a early_stage_venture and late_stage_venture and seed firm.

British Patient Capital

British Patient Capital

British Patient Capital is a late_stage_venture firm.

Participant Investors

6

Investor Name
Participant InvestorUCL Technology Fund
Participant InvestorBritish Patient Capital
Participant InvestorSofinnova Partners
Participant InvestorF-Prime Capital
Participant InvestorEight Roads Ventures

Round Details and Background

Tenpoint Therapeutics raised $70000000 on 2023-07-12 in Series A

Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 12, 2023
Series A - Tenpoint Therapeutics
6-70.0M

Recent Activity

There is no recent news or activity for this profile.